Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment 

Merck & Co.'s immunotherapy cancer drug Keytruda received U.S. Food and Drug Administration approval as a first-line treatment for certain lung cancer patients. (published 0020 GMT)

 
 
CapitaLand Retail China Trust: 3Q Distribution Per Unit 2.36 Singapore Cents, Down 11% On Year 

CapitaLand Retail China Trust, a Singapore-based real estate investment trust, said Tuesday that its third-quarter distribution per unit dropped 11% from a year earlier to 2.36 Singapore cents, due to weaker net property income. (published 0045 GMT)

 
 
Quam Expects April-Sept Results to Worsen Significantly From Year Earlier 

Financial services company Quam Ltd. said late Monday it expects its April-September financial results to worsen significantly from a year earlier due to weak market sentiment. (published 0054 GMT)

 
 
AT&T's Deal for Time Warner Faces Tough Climate 

AT&T Inc.'s $85.4 billion deal to buy Time Warner Inc. sails toward two cresting waves of opposition: resurgent antitrust enforcement in Washington and politicians fired by a new bipartisan populist rage. (published 2248 GMT Monday)

 
 
Visa Profit Rises 28% as Results Top Wall Street Views -- 3rd Update 

Visa Inc.'s earnings for the fiscal fourth quarter rose 28%, driven by growth in payments volume and processed transactions and its recent acquisition of sister company Visa Europe. (published 2244 GMT Monday)

 
 
Genworth, China Oceanwide Chart Path to Regulatory Approval of Deal 

Genworth Financial Inc.'s proposed buyout by a Chinese conglomerate drew skepticism in the market that the deal would get done, even as some state regulators are privately embracing the possible acquisition, according to people familiar with the matter. (published 2240 GMT Monday)

 
 
Swift Transportation Posts Higher Profit, Lower Revenue 

Trucking company Swift Transportation Co., which has adopted cost controls including scaling back its fleet amid tough market conditions, posted a 4.7% profit increase in the third quarter despite lower revenue. (published 2230 GMT Monday)

 
 
MetLife v. FSOC Oral Arguments: Four Key Exchanges 

If you missed Monday morning's oral arguments between lawyers for MetLife Inc. and the Financial Stability Oversight Council at the U.S. Court of Appeals for the District of Columbia, WSJ Pro Financial Regulation has you covered. Here are four important exchanges where judges probed lawyers for both sides. For more background on the case, read our previous coverage here and here. (published 2228 GMT Monday)

 
 
Buckeye Partners to Buy Joint Stake in Vitol's VTTI Marine Terminal Business 

Pipeline company Buckeye Partners LP reached a $1.15 billion cash deal for a joint stake in Vitol's VTTI BV, which would give Buckeye access to marine terminals in key energy hubs in Europe, the United Arab Emirates and Singapore. (published 2208 GMT Monday)

 
 
Gannett Plans to Cut 2% of Its Workforce 

Gannett Co. plans to cut 2% of jobs and invest in more acquisitions to transform its business, according to a memo to staff, as the newspaper industry struggles with a particularly turbulent advertising environment. (published 2145 GMT Monday)

 
 
Goodyear Plans to Close German Plant As Part of Broader Realignment 

Goodyear Tire & Rubber Co. intends to shut down a plant in Germany as part of a broader realignment plan to focus on more profitable premium, large-rim tires. (published 2141 GMT Monday)

 
 
Zions Bancorp Profit Rises 26% 

Zions Bancorp said its third-quarter earnings rose 26% amid better-than-expected revenue growth and stronger margins, though the regional lender's loan portfolio remained under pressure from its exposure to weakness in the oil-and-gas sector. (published 2127 GMT Monday)

(END) Dow Jones Newswires

October 24, 2016 21:00 ET (01:00 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.